Disposal of businesses within the Ascendis Health Biosciences division: Transaction unconditional
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
(“Ascendis Health” or “the Company”)
Disposal of Afrikelp, Efekto and Marltons businesses within the Ascendis Health Biosciences division:
Shareholders are referred to the announcement published by the Company on 2 May 2019 relating to
the restructure and the subsequent disposal of certain entities and businesses within Ascendis
Health’s Biosciences division to a consortium comprising RMB Ventures Seven Proprietary Limited,
Nedbank Private Equity and certain members of management of the Ascendis Health Biosciences
division (“the Transaction”).
The Company’s board of directors is pleased to advise that all conditions precedent, which included
approval from the Competition board, to the Transaction have been fulfilled and accordingly the
Transaction has become unconditional.
The effective date of the Transaction was 31 March 2019.
The two remaining businesses in the Ascendis Health Biosciences division, being Avima Proprietary
Limited and Klub M5 Proprietary Limited, are now being considered for divestment. Shareholders will
be advised accordingly of further details as appropriate.
31 July 2019
Questco Corporate Advisory (Proprietary) Limited
Date: 31/07/2019 12:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Email this JSE Sens Item to a Friend.